1 enrolling by invitation. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow treated group: new trials by email Literature Review of treated group trials Research Report on treated group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents treated group - Histiocytosis,Langerhans-Cell | Phase 1 / Phase 2 | Enrolling by invitation | Second Affiliated Hospital of Wenzhou Medical University | 2 | 2026-10-20 | 2026-10-22 |
Histiocytosis, Langerhans-Cell (1)
Second Affiliated Hospital of Wenzhou Medical University (1)
China (1)